Scroll Up

Innovate and Advance in vivo Gene Therapy
Learn More
Pioneer one-and-done Genome Editing Medicines to
Transform lives of patients with serious diseases
Learn More

ABOUT US

YolTech is a pioneering gene editing company dedicated to developing a robust gene editing medicines to treat patients with serious diseases.

Learn More

LEADERSHIP

LEADERSHIP

JOIN US

JOIN US

CORE VALUES

CORE VALUES

OUR SCIENCE

GENOME EDITING PLATFORM Learn More
DELIVERY PLATFORM Learn More
MANUFACTURE Learn More

YolTech has led the translation of in vivo gene editing using mRNA-LNP (Messenger RNA-Lipid Nanoparticle) delivery system, our science and technology keeps unlocking precise editing tools, novel delivery system and treatment of diseases.

Learn More
PIPELINE

Our mission is to offer cutting-edge in vivo gene editing therapy that leads the way in treating serious diseases with limited treatment options, giving patients access to groundbreaking medical solutions.

Learn More

NEWS

Our News

重磅 | 尧唐自主开发新型可电离脂质专利获授权,实现核酸药物递送技术突破

2023年6月1日,由尧唐(上海)生物科技纳米递送技术平台团队自主开发的新型可电离脂质专利【2022107255487】(脂质化合物、包含其的组合物及应用)在中国大陆获得授权。

Our News

华东医药旗下珲信生物与尧唐生物达成战略合作

Global Updates

基因编辑治疗高胆固醇血症入选《麻省理工科技评论》2023全球十大突破性技术

Global Updates

Intellia:第2款体内基因编辑疗法取得积极数据

CONTACT US

Tel :021-52260086 Email:info@yoltx.com

沪ICP备2021023151号-1

COPY ? YolTech 沪公网安备31011202013743号

Powered By VTHINK

CONTACT US

info@yoltx.com

021-52260086

XML 地图 | Sitemap 地图